Rhodirubin E
Molecular Formula:
C42H55NO17
InChI: InChI=1/C42H55NO17/c1-8-42(53)15-26(30-19(34(42)41(52)54-7)11-20-31(37(30)50)38(51)33-23(45)10-9-22(44)32(33)36(20)49)58-27-12-21(43(5)6)39(17(3)56-27)59-29-14-25(47)40(18(4)57-29)60-28-13-24(46)35(48)16(2)55-28/h9-11,16-18,21,24-29,34-35,39-40,44-48,50,53H,8,12-15H2,1-7H3/t16u,17u,18u,21?,24?,25?,26-,27?,28?,29?,34-,35?,39?,40?,42+/m0/s1
InChIKey: InChIKey=VJRAUFKOOPNFIQ-LOUGPCCRBU
SMILES: CCC1(CC(C2=C(C1C(=O)OC)C=C3C(=C2O)C(=O)C4=C(C=CC(=C4C3=O)O)O)OC5CC(C(C(O5)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)O)O)N(C)C)O
Names:
Marcellomycin
methyl (1R,2R,4S)-4-[5-[5-(4,5-dihydroxy-6-methyl-oxan-2-yl)oxy-4-hydroxy-6-methyl-oxan-2-yl]oxy-4-dimethylamino-6-methyl-oxan-2-yl]oxy-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
NSC 265211
NSC265211
Replaced CAS registry number(s): 64256-11-7
Rhodirubin E
1-Naphthacenecarboxylic acid, 4-[[O-2, 6-dideoxy-.alpha.-L-lyxo-hexopyranosyl- (1.fwdarw.4)-O-2, 6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3, 6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-e thyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester,[1R-(1.alpha.,2.beta.,4.beta.)]-
1-Naphthacenecarboxylic acid, 4-[[O-2, 6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1 4)-O-2, 6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1 4)-2,3, 6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-e thyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-,
1-Naphthacenecarboxylic acid, 4-[[O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl- (1.fwdarw.4)-O-2, 6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3, 6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-e thyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-, methyl ester, (1R-(1.alpha.,2.beta.,4.beta.))-
63710-10-1
Registries:
PubChem CID 319748
PubChem ID 139728
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|